Friday March 19 2010 |
Biotechnology feed
|
All feeds
Home
Marketing Services
Antibodies
Careers
Directories
Drugs
Events
Genes
InDepth
News
Reports
Videos
A-Z
Business
Health
Drugs
Sources
Americas
Europe
Asia
Cancer
Cardio-
Diabetes
Bird Flu
Swine Flu
Summaries
Post News
Search
Lymphocytic News and Headlines
Lymphocytic News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's
Lymphocytic
news alerts
.
Site Map
>
Biotechnology News
>
Health News
> Lymphocytic
.
Assessment of Peripheral Blood and Bone Marrow Cells Apoptosis Caused by Purine Analogues in Patients with Chronic Lymphocytic Leukemia in Correlation with Parameters of Disease Progression
Acta Haematologica:
similar ...
Medical News: NICE Set To Recommend Rituximab For Relapsed Or Refractory Chronic Lymphocytic Leukaemia
BioFind:
similar ...
NICE Set To Recommend Rituximab For Relapsed Or Refractory Chronic Lymphocytic Leukaemia
Medical News Today:
similar ...
Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia [Hematolo
Journal of Clinical Oncology:
similar ...
Rituxan Approved for Chronic Lymphocytic Leukemia
Cancer Consultants:
similar ...
FDA Approves Rituxan for Chronic Lymphocytic Leukemia
BioPharm International:
similar ...
FDA Expands Use Of Rituxan For Chronic Lymphocytic Leukemia (DJ)
Easy Bourse:
similar ...
FDA Approves Rituxan Plus Chemotherapy for the Most Common Type of Adult Leukemia
PharmiWeb:
similar ...
Rituxan Approved for Chronic Lymphocytic Leukemia
Modern Medicine:
similar ...
FDA Approves Rituxan Plus Chemotherapy for the Most Common Type of Adult Leukemia
Pharma Live:
similar ...
Rituxan Approved for Chronic Lymphocytic Leukemia
National Womens Health Information Center:
similar ...
FDA Approves Rituximab for Chronic Lymphocytic Leukemia
Medscape:
similar ...
FDA Approves Rituximab for Chronic Lymphocytic Leukemia
Abstracts in Hematology and Oncology:
similar ...
Medical News: FDA Approves Rituxan To Treat Chronic Lymphocytic Leukemia
BioFind:
similar ...
FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
Pharma Live:
similar ...
FDA Approves Rituximab to Treat Chronic Lymphocytic Leukaemia
Doctors Guide:
similar ...
FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
Pharmacy Choice:
similar ...
FDA Approves Rituximab to Treat Chronic Lymphocytic Leukaemia
PSL Group:
similar ...
2/18/10 - FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
Pharmacy Choice:
similar ...
Rituxan anti-cancer drug receives FDA approval
News-Medical.Net:
similar ...
